Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Therapeutic Drug Monitoring|June 1, 1996
Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free systemL I Harrison, A Cline, T M Wells, et al.American Heart Journal|October 1, 1984
Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxinR DiBianco, J Morganroth, J A Freitag, et al.Journal of the American College of Cardiology|July 1, 1985
Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular functionS R Spielman, A M Greenspan, H R Kay, et al.American Journal of Surgery|May 13, 2014
p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal diseaseTobias Leibold, Vanessa W Hui, Jinru Shia, et al.The American Journal of Cardiology|February 1, 1985
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart diseaseL N Horowitz, A M Greenspan, S R Spielman, et al.Journal of Medical Entomology|February 8, 2012
Dispersal of Culex mosquitoes (Diptera: Culicidae) from a wastewater treatment facilityAlexander T Ciota, Cori L Drummond, Meghan A Ruby, et al.Physiological Reports|June 16, 2018
Retained differentiation capacity of human skeletal muscle satellite cells from spinal cord-injured individualsMladen Savikj, Maxwell A Ruby, Emil Kostovski, et al.Journal of the American Mosquito Control Association|April 12, 2011
Emergence of Culex pipiens from overwintering hibernaculaAlexander T Ciota, Cori L Drummond, Jason Drobnack, et al.Plos One|November 11, 2011
Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genesMaxwell A Ruby, Daniel K Nomura, Carolyn S S Hudak, et al.Antimicrobial Agents and Chemotherapy|January 30, 1999
Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patientsK C Cundy, P Barditch-Crovo, B G Petty, et al.Pageof 21